SRRK

Scholar Rock Holding Corporation

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$43.16

Price (1 Year)

$57.8 $39.9

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %7.6 / %30
Non-compliant assets / Total market cap %2.1 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform.

Website

Analysis (Turkish): SRRK Hissesi Caiz mi, Helal mi? Scholar Rock Holding Corporation Katılım Analizi